Subject: Re: BOLIVIA - Renewals in 2026 - ARIAD PHARMACEUTICALS INC. - Deadline: 05/31/2026
From: Paula Alfaro <[email-masked]>
To: Terri Morris <[email-masked]>
Cc: Guillermo Lopez <[email-masked]>, International Bolet & Terrero <[email-masked]>
Date: Thu, 26 Feb 2026 16:00:33 +0000

Dear Terri,

Thank you for your response. We have taken due note of your comments.

We remain at your service in case you need our assistance.

Best regards,

________________________________
From: Terri Morris <[email-masked]>
Sent: Thursday, February 26, 2026 11:52 AM
To: Paula Alfaro <[email-masked]>
Cc: Guillermo Lopez <[email-masked]>; International Bolet & Terrero <[email-masked]>
Subject: RE: BOLIVIA - Renewals in 2026 - ARIAD PHARMACEUTICALS INC. - Deadline: 05/31/2026

Paula,

We are unable to provide instructions as we no longer manage this portfolio.  The company was purchased by Takeda years ago and we have no contact information for them.

Regards,
Terri

Teresa H. Morris

Trademark Paralegal

Tepper & Eyster, PLLC

This e-mail is sent by a law firm and may contain information that is privileged or confidential.  If you are not the intended recipient, please delete the e-mail and any attachments and notify us immediately.

From: Paula Alfaro <[email-masked]>
Sent: Thursday, February 26, 2026 10:32 AM
To: Terri Morris <[email-masked]>
Cc: Guillermo Lopez <[email-masked]>; International Bolet & Terrero <[email-masked]>
Subject: BOLIVIA - Renewals in 2026 - ARIAD PHARMACEUTICALS INC. - Deadline: 05/31/2026
Importance: High

Dear Colleagues,

We hope this email finds you well. According to our records, the below registered trademark in Bolivia is due for renewal in 2026:

Mark

Class

Reg. No.

Renewal date

Owner

ICLUSIG

5

166519-C

05/31/2026

ARIAD PHARMACEUTICALS, INC.

Kindly let us know if the client would be interested in filing a renewal so we can send you further information.

Looking forward to hearing from you.

Best regards,